Aortic baroreceptor afferents as sensors for systemic inflammation - Report - MDSpire

Aortic baroreceptor afferents as sensors for systemic inflammation

  • By

  • Fernanda Brognara

  • Jaci Airton Castania

  • Mirele Resende Machado

  • José Teles de Oliveira Neto

  • Helio Cesar Salgado

  • Rita de Cassia Tostes

  • Daniel Penteado Martins Dias

  • Julian Francis Richmond Paton

  • Evelin Capellari Cárnio

  • June 12, 2026

  • 0 min

Share

Clinical Report: Aortic Baroreceptor Afferents as Sensors for Inflammation

Overview

This study investigates the role of aortic baroreceptor afferents in sensing systemic inflammation. Findings suggest that these afferents may modulate central autonomic activity in response to inflammatory signals, potentially linking cardiovascular and immune dysfunction.

Background

The interplay between the nervous and immune systems is crucial for regulating inflammation and maintaining homeostasis. Dysregulation of these systems can lead to severe conditions such as sepsis and cardiovascular collapse. Understanding how baroreceptors may function as immunosensors could inform new therapeutic strategies for inflammatory diseases.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Aortic baroreceptors may detect inflammatory signals and modulate autonomic responses.
  • Baroreceptor denervation in endotoxemic rats reduced pro-inflammatory cytokine levels.
  • Baroreceptors express receptors for cytokines, indicating a role in immune signaling.
  • Activation of sensory fibers can trigger the inflammatory reflex to reduce systemic inflammation.
  • This study establishes a methodology for analyzing gene and protein expression in aortic depressor nerves.

Clinical Implications

The findings suggest that targeting baroreceptor pathways may offer new avenues for treating conditions associated with systemic inflammation, such as sepsis. Understanding the dual role of baroreceptors could enhance therapeutic strategies for managing cardiovascular and immune dysfunction.

Conclusion

The study highlights the potential of aortic baroreceptor afferents as critical sensors in the inflammatory response, paving the way for future research into their therapeutic applications.

Related Resources & Content

  1. Basic Research in Cardiology, Springer Nature, 2026 -- Aortic baroreceptor afferents as sensors for systemic inflammation
  2. European Journal of Preventive Cardiology — Baroreflex: ready for prime-time?
  3. Basic Research in Cardiology — Serum Amyloid A's Role in HFpEF and Associated Cardiometabolic Disorders
  4. Clinical Research in Cardiology — Progression of Abdominal Aortic Aneurysms: An Overview of Clinical and Preclinical Evidence
  5. Archives of Toxicology — Role of Aryl Hydrocarbon Receptor (AHR) in Infectious and Non-Infectious Inflammation and Metabolic Adaptation via NAD+ Dependency
  6. Clinical Outcome Assessments Inform Indications for Use in Breakthrough Heart Failure Symptoms Device | FDA
  7. Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure Trial | JACC: Heart Failure
  8. Aortic baroreceptor afferents as sensors for systemic inflammation | Basic Research in Cardiology | Springer Nature Link

Original Source(s)

Aortic baroreceptor afferents as sensors for systemic inflammation

  • by Fernanda Brognara, Jaci Airton Castania, Mirele Resende Machado, José Teles de Oliveira Neto, Helio Cesar Salgado, Rita de Cassia Tostes, Daniel Penteado Martins Dias, Julian Francis Richmond Paton, Evelin Capellari Cárnio

  • June 12, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Acute Kidney Injury Therapies Reviewed

Several interventions show early promise in high-risk patients, yet the field still awaits its first proven targeted therapy.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.